Deere & Company’s Kyntra Bio KYNB Stock Holding History

Deere & Company’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,007	Closed	-$413K	–	1049
2016 Q2	$413K	Buy	+1,007	New	+$461K	0.02%	734

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deere & Company's KYNB Position: Q3 2016 in Review

Deere & Company sold out of Kyntra Bio (KYNB) in Q3 2016, closing a stake of 1,007 shares — an estimated $413K sold.

Deere & Company first reported a position in KYNB in Q2 2016 and held it in 1 quarter. The position peaked at $413K in Q2 2016. 133 funds tracked by Wall St. Rank hold KYNB as of Q3 2016.

Deere & Company reported no remaining Kyntra Bio position as of Q3 2016 after selling out during the quarter.
Deere & Company sold 1,007 Kyntra Bio shares in Q3 2016, an estimated $413K.
Deere & Company first reported a position in Kyntra Bio in Q2 2016 and held it in 1 quarter.
Deere & Company's Kyntra Bio position peaked at $413K in Q2 2016.
133 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.